Meningitis outbreak in UK suggests vigilance is required even if cases are rare
The UK is currently facing a meningitis outbreak, especially in the younger population. The outbreak started in Kent, south-east of …
Post
-
-
LabConnect unveils SampleGISTICS 2.0 for trial sample digitisation
LabConnect has introduced the smartphone-based SampleGISTICS 2.0 application to digitise clinical trial sample capture. With the new application, clinical research staff will be …
-
AstraZeneca reports positive data from Phase III trial of efzimfotase alfa
AstraZeneca has reported positive results from the efzimfotase alfa Phase III clinical trial programme for hypophosphatasia (HPP), a rare metabolic …
-
ACC 2026: pooled analysis supports early dapagliflozin use in acute HF care
On 30 March, at this year’s American College of Cardiology (ACC) Scientific Session, during a poster contributions session on the …
-
Boston Scientific presents Watchman FLX and EKOS endovascular system data
Boston Scientific has shared a duo of positive data readouts from two separate trials evaluating its Watchman FLX left atrial appendage …
-
ACC 2026: pooled analysis supports early dapagliflozin use in acute HF care
On 30 March, at this year’s American College of Cardiology (ACC) Scientific Session, during a poster contributions session on the …
-
Boston Scientific presents Watchman FLX and EKOS endovascular system data
Boston Scientific has shared a duo of positive data readouts from two separate trials evaluating its Watchman FLX left atrial appendage …
-
MoonLake’s lead asset shows durability in late-stage HS studies
MoonLake Immunotherapeutics’ targeted therapy, sonelokimab, has offered long-term disease-modifying and quality of life (QoL)-boosting benefits during two Phase III hidradenitis …
-
MSD boasts data for oral PCSK9 inhibitor as add on therapy
MSD’s oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor has reduced low-density lipoprotein cholesterol (LDL-C) levels when combined with background …
-
Idorsia reports positive data for paediatric insomnia study of daridorexant
Idorsia has reported positive top-line data from its Phase II dose-finding trial evaluating daridorexant, a dual orexin receptor antagonist, for …
-
Prilenia and Ferrer enrol first participant in PREVAiLS Phase III trial
Prilenia Therapeutics and Ferrer have enrolled the first participant in the pivotal Phase III PREVAiLS clinical trial assessing pridopidine in …
-
From compliance to culture: Lessons from a quality leader on pharma’s next imperative
We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment, …
-
J&J’s Spravato touts durable anti-depressant benefits in real-world study
A real-world study has revealed the long-term impact of Johnson & Johnson’s (J&J) Spravato (esketamine) in treatment-resistant depression (TRD), which …
-
Ayahuasca-derived DMT study shows positive effects on depression therapy in trials
Interest in psychedelic medicines has accelerated in recent years, and new research focusing on dimethyltryptamine (DMT), the main psychoactive compound …
-
Viridian Therapeutics’ stock sinks despite positive Phase III TED data
Viridian Therapeutics stock has fallen by 38%, despite its active thyroid eye disease (TED) drug meeting the primary endpoints of …
